Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 17, Number 1—January 2011

Dispatch

Foreign Travel and Decreased Ciprofloxacin Susceptibility in Salmonella enterica Infections

Manar Al-Mashhadani, Robert Hewson, Roberto Vivancos, Alex Keenan, Nick J. Beeching, John Wain, and Christopher M. ParryComments to Author 
Author affiliations: Author affiliations: University of Liverpool, Liverpool, UK (M. Al-Mashhadani, R. Hewson, C.M. Parry); Health Protection Agency Moorgate Point, Liverpool (R. Vivancos, A. Keenan); University of Manchester, Manchester, UK (R. Vivancos); Liverpool School of Tropical Medicine, Liverpool (N.J. Beeching); Health Protection Agency Colindale, London, UK (J. Wain)

Main Article

Table

Relationship between nontyphoidal Salmonella enterica serovar, phage type, nalidixic acid resistance, and history of foreign travel, Liverpool, UK, 2003–2009*

Serovar
Total no. (%) patient isolates
No. (%) patients with foreign travel history
No. (%) patients with nalidixic acid–resistant isolate
No. (%) patients with foreign travel history and nalidixic acid–resistant isolate
All 492 (100.0) 110 (22.4) 103 (20.9) 35 (31.8)
Enteritidis PT1 53 (10.8) 16 (30.2) 36 (67.9) 9 (56.3)
Enteritidis PT4 93 (18.9) 12 (12.9) 4 (4.3) 2 (16.7)
Enteritidis PT8 43 (8.7) 8 (18.6) 1 (2.3) 1 (12.5)
Enteritidis PT21 22 (4.5) 5 (22.7) 10 (45.4) 1 (20.0)
Enteritidis (other PT) 104 (21.1) 13 (12.5) 16 (15.4) 3 (23.1)
Typhimurium 44 (8.9) 11 (25.0) 3 (6.8) 1 (9.1)
Newport 14 (2.8) 3 (21.4) 8 (57.1) 3 (100.0)
Virchow 12 (2.4) 9 (75.0) 11 (91.7) 8 (88.9)
Other 107 (21.7) 33 (30.8) 14 (13.1) 7 (21.2)

*PT, phage type.

Main Article

Top of Page

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO